These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2975501)
61. Sensitivity and specificity of plasma serine protease chromogenic substrates. Bang NU; Mattler LE Haemostasis; 1978; 7(2-3):98-104. PubMed ID: 149051 [TBL] [Abstract][Full Text] [Related]
62. Kinetics of the reaction of streptokinase-plasmin complex with purified human and mouse alpha 2-macroglobulin. Implications for mechanism. Anonick PK; Vetter WH; Gonias SL Biochem J; 1989 Dec; 264(3):745-52. PubMed ID: 2482733 [TBL] [Abstract][Full Text] [Related]
63. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses. Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093 [TBL] [Abstract][Full Text] [Related]
64. A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci. Wang H; Lottenberg R; Boyle MD J Infect Dis; 1995 Jan; 171(1):85-92. PubMed ID: 7798686 [TBL] [Abstract][Full Text] [Related]
65. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin. Ts'ao C; Galluzzo TS Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054 [TBL] [Abstract][Full Text] [Related]
66. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin. Gonias SL; Einarsson M; Pizzo SV J Clin Invest; 1982 Aug; 70(2):412-23. PubMed ID: 6178757 [TBL] [Abstract][Full Text] [Related]
67. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase]. Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011 [TBL] [Abstract][Full Text] [Related]
68. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
69. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy. Crabbe SJ; Grimm AM; Hopkins LE Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889 [TBL] [Abstract][Full Text] [Related]
70. The acyl-enzymes and pro-urokinase: promising new thrombolytic agents. Samama M; Horellou MH; Nguyen G; Conard J Haemostasis; 1986; 16 Suppl 3():33-7. PubMed ID: 3095196 [No Abstract] [Full Text] [Related]
71. [Thrombolytic drugs in acute myocardial infarct]. Ambrosioni E; Degli Esposti D Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796 [TBL] [Abstract][Full Text] [Related]
72. Fibrinolysis--a review. Kane KK Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587 [TBL] [Abstract][Full Text] [Related]
73. A streptokinase dependent plasma factor (SKDF) induces leucocyte tissue factor activity. Niemetz J; Kang S Br J Haematol; 1988 Dec; 70(4):427-33. PubMed ID: 2975501 [TBL] [Abstract][Full Text] [Related]